Endotoxin and tumor necrosis factor-alpha-induced interleukin-8 release in humans

J Infect Dis. 1993 Feb;167(2):461-54. doi: 10.1093/infdis/167.2.461.

Abstract

Neutrophil recruitment and activation are thought to play an important role in tissue damage observed in septicemia. Interleukin-8 (IL-8) is a small cytokine with important neutrophil-activating and chemoattractant properties. IL-8 release was studied after injection of human volunteers with low doses of either endotoxin (2 ng/kg of body weight) or tumor necrosis factor-alpha (TNF alpha) (50 micrograms/m2). After TNF-alpha injection, IL-8 appeared at 30 min, whereas increased levels were first observed after 90 min in endotoxin-challenged volunteers. Peak levels were measured at 120 min after both endotoxin (192 +/- 193 ng/L) and TNF alpha (500 +/- 236 ng/L) injection. These data indicate that IL-8 is released in humans after injection of endotoxin and TNF alpha and suggest that endotoxin-induced IL-8 release is mediated by TNF alpha.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Endotoxins / administration & dosage
  • Endotoxins / pharmacology*
  • Escherichia coli*
  • Humans
  • Injections, Intravenous
  • Interleukin-8 / metabolism*
  • Tumor Necrosis Factor-alpha / administration & dosage
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Endotoxins
  • Interleukin-8
  • Tumor Necrosis Factor-alpha
  • endotoxin, Escherichia coli